Order Article Reprints

Khoury JD, Tashakori M, Yang H, Loghavi S, Wang Y, Wang J, Piya S, Borthakur G. Pan-RAF Inhibition Shows Anti-Leukemic Activity in RAS-Mutant Acute Myeloid Leukemia Cells and Potentiates the Effect of Sorafenib in Cells with FLT3 Mutation. Cancers. 2020; 12(12):3511. https://doi.org/10.3390/cancers12123511

Khoury, Joseph D., Mehrnoosh Tashakori, Hong Yang, Sanam Loghavi, Ying Wang, Jing Wang, Sujan Piya, and Gautam Borthakur. 2020. "Pan-RAF Inhibition Shows Anti-Leukemic Activity in RAS-Mutant Acute Myeloid Leukemia Cells and Potentiates the Effect of Sorafenib in Cells with FLT3 Mutation" Cancers 12, no. 12: 3511. https://doi.org/10.3390/cancers12123511

Khoury, J. D., Tashakori, M., Yang, H., Loghavi, S., Wang, Y., Wang, J., Piya, S., & Borthakur, G. (2020). Pan-RAF Inhibition Shows Anti-Leukemic Activity in RAS-Mutant Acute Myeloid Leukemia Cells and Potentiates the Effect of Sorafenib in Cells with FLT3 Mutation. Cancers, 12(12), 3511. https://doi.org/10.3390/cancers12123511